Πρωτεύουσες καρτέλες
Ο κατάλογος των δημοσιεύσεων είναι ενδεικτικός και μπορεί να μην περιλαμβάνει το σύνολο των δημοσιεύσεων.
Imaging Patterns of Cardiovascular Involvement in Mixed Connective Tissue Disease Evaluated by Cardiovascular Magnetic Resonance..
Inflamm Allergy Drug Targets. 14(2), 111-6.
(2015).
Cumulative inflammation associates with asymmetric dimethylarginine in rheumatoid arthritis: a 6 year follow-up study..
Rheumatology (Oxford). 54(7), 1145-52.
(2015).
Symmetric dimethylarginine (SDMA) serum levels in rheumatoid arthritis: correlations with insulin resistance and disease activity scores..
Amino Acids. 47(9), 1995-2004.
(2015).
Molecular and cellular pathways as treatment targets for biologic therapies in systemic sclerosis..
Curr Med Chem. 22(16), 1943-55.
(2015).
Infliximab as a treatment option for patients with rheumatoid arthritis and primary biliary cirrhosis..
Rheumatol Int. 35(11), 1913-6.
(2015).
Individualised exercise improves endothelial function in patients with rheumatoid arthritis..
Ann Rheum Dis. 73(4), 748-51.
(2014).
Osteoarthritis pain has a significant neuropathic component: an exploratory in vivo patient model..
Rheumatol Int. 34(3), 315-20.
(2014).
Asymmetric dimethylarginine is not associated with subendocardial viability ratio in Rheumatoid Arthritis..
Int J Cardiol. 172(1), 285-6.
(2014).
Rheumatoid arthritis: an autoimmune disease with female preponderance and cardiovascular risk equivalent to diabetes mellitus: role of cardiovascular magnetic resonance..
Inflamm Allergy Drug Targets. 13(2), 81-93.
(2014).
Edema and fibrosis imaging by cardiovascular magnetic resonance: how can the experience of Cardiology be best utilized in rheumatological practice?.
Semin Arthritis Rheum. 44(1), 76-85.
(2014).
Cardiac and muscular involvement in idiopathic inflammatory myopathies: noninvasive diagnostic assessment and the role of cardiovascular and skeletal magnetic resonance imaging..
Inflamm Allergy Drug Targets. 13(3), 206-16.
(2014).
Neuropathic pain in osteoarthritis: a review of pathophysiological mechanisms and implications for treatment..
Semin Arthritis Rheum. 44(2), 145-54.
(2014).
Relationship between dimethylarginine dimethylaminohydrolase gene variants and asymmetric dimethylarginine in patients with rheumatoid arthritis..
Atherosclerosis. 237(1), 38-44.
(2014).
Why currently used diagnostic techniques for heart failure in rheumatoid arthritis are not enough: the challenge of cardiovascular magnetic resonance imaging..
Rev Cardiovasc Med. 15(4), 320-31.
(2014).
Micro- and macrovascular treatment targets in scleroderma heart disease..
Curr Pharm Des. 20(4), 536-44.
(2014).
Lack of association between polymorphisms of thrombogenic genes and disease susceptibility in rheumatoid arthritis..
Rheumatol Int. 33(9), 2429-32.
(2013).
Biologic therapies and systemic bone loss in rheumatoid arthritis..
Autoimmun Rev. 12(10), 958-66.
(2013).
Derangement of hemostasis in rheumatoid arthritis: association with demographic, inflammatory and metabolic factors..
Clin Rheumatol. 32(9), 1357-64.
(2013).
Heart involvement in rheumatoid arthritis: multimodality imaging and the emerging role of cardiac magnetic resonance..
Semin Arthritis Rheum. 43(3), 314-24.
(2013).
Clinical outcome of ultrasound-guided steroid injections for chronic shoulder pain..
Int J Rheum Dis. 16(4), 398-402.
(2013).
Systemic sclerosis-related pulmonary hypertension: unique characteristics and future treatment targets..
Curr Pharm Des. 18(11), 1457-64.
(2012).
B-type natriuretic peptide in rheumatic diseases: a cardiac biomarker or a sophisticated acute phase reactant?.
Autoimmun Rev. 11(12), 837-43.
(2012).
Significance of serum uric acid in pulmonary hypertension due to systemic sclerosis: a pilot study..
Rheumatol Int. 31(2), 263-7.
(2011).
Biomarkers in systemic sclerosis-related pulmonary arterial hypertension..
Curr Vasc Pharmacol. 9(2), 213-9.
(2011).